30 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year.
21 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from NYSE regarding delayed Form 20-F filing.
60 Biggest Movers From Yesterday
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.
Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge
Midway through trading Monday, the Dow traded down 1.23% to 35,787.07 while the NASDAQ fell 2.07% to 14,627.21. The S&P also fell, dropping, 1.52% to 4,605.95.
45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
20 Stocks Moving in Monday’s Pre-Market Session
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) rose 32.1% to $4.53 in pre-market trading.
Novartis To In-License COVID-19 Treatment From Molecular Partners, After Encouraging Mid-Stage Data
After getting positive trial data, Novartis AG (NYSE: NVS) said it would in-license a new drug developing with Molecular Partners AG (NASDAQ: MOLN) to treat COVID-19.
Molecular Partners and Novartis Report Topline Data from Phase 2 Study for Ensovibep Show DARPin Antiviral Therapeutic Candidate for COVID-19 vs. Placebo Met Primary Endpoint of Viral Load Reduction over Eight Days
Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Novartis today announced that Part A of the EMPATHY clinical trial1, that compared single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs.
